Patient, physician, and policy factors underlying variation in use of telemedicine for radiation oncology cancer care.
Brian Sandeep DeShuangshuang FuYing-Shiuan ChenPrajnan DasKimberly KuSean MaroongrogeKristina D WoodhouseKaren E HoffmanQuynh-Nhu NguyenValerie K ReedAileen B ChenAlbert C KoongBenjamin D SmithGrace L SmithPublished in: Cancer medicine (2022)
Though toxicities were similar with telemedicine oncology management, there remained lower uptake among non-White patients. Continuing strategies for oncology telemedicine implementation should address multilevel patient, physician, and policy factors to optimize telemedicine's potential to surmount-and not exacerbate-barriers to quality cancer care.